Bryanwillisusa · Newsroom

Biogetica partners with Research Needs for Ground Breaking Clinical Trials in HPV & Other Ailments!
The immediate plan for 2018 is to launch clinical trials and observational studies for HPV, Herpes, Trigeminal Neuralgia, Vertigo, Tinnitus, and Cataract.

May 30, 2018

Biogetica’s Clinically Tested, New and Improved Protocol for Auditory, Nervous, and Circulatory
Vertigo is indeed a troublesome condition and if left untreated can progressively worsen to become debilitating ruining one’s quality of life.

November 6, 2017

Treatment of Parkinson’s Disease Reports Biogetica’s Research Center
Biogetica’s brilliant work in brain health management can be seen in the results obtained in independent clinical trials and thousands of lives improved.

October 10, 2017

Biogetica’s New and Improved Protocol for Scabies is Witnessing Unprecedented Results
Scabies is a very troublesome and highly contagious infection and the chemicals prescribed to eradicate the mites only offer temporary relief.

October 4, 2017

Biogetica’s New and Improved Protocol for Trigeminal Neuralgia
Trigeminal Neuralgia is one of the most painful conditions known to man and is often called the suicide disease.

September 27, 2017

Biogetica’s Patented Hyperisince Product Brings With it a New Ray of Hope for HPV sufferers.
Biogetica’s Hyperisince has already received a Patent Number 808/MUM/2013 by The Indian Patent Office and also has a Patent Pending in the USA

September 20, 2017

Biogetica Announces Herpes Treatment Study
International Journal of Research In Ayurveda and Pharmacy publishes groundbreaking herpes study on Biogetica’s Hyperisince Formula

July 19, 2017